Showing 1281-1290 of 2155 results for "".
- Why I Sold: Dr. Brian Biesman Joins MedSpa Partnershttps://modernaesthetics.com/news/why-i-sold-dr-brian-biesman-joins-medspa-partners/2473487/Nashville-based oculofacial plastic surgeon Dr. Brian Biesman is joining MedSpa Partners (MSP) Inc. "I'm excited for us to join such a talented and accomplished group of practices and practitioners. We have always prided ourselves on our commitment to rigorously
- BBL Safety Update: AACS Supports New Florida Bill Mandating Ultrasound-guided BBL Surgeryhttps://modernaesthetics.com/news/bbl-safety-update-aacs-supports-new-florida-bill-mandating-ultrasound-guided-bbl-surgery/2473483/The American Academy of Cosmetic Surgery (AACS) strongly commends the Florida legislature for its ongoing commitment to promoting patient safety in Brazilian Butt Lift (BBL) surgery and applauds the recent legislative decision that mand
- Dr. Ashley Brissette Is Clinique’s First Guiding Ophthalmologisthttps://modernaesthetics.com/news/nyc-ophthalmologist-dr-ashley-brissette-is-cliniques-first-guiding-ophthalmologist/2473481/NYC-based ophthalmologist Ashley Brissette, MD, MSc, FRCSC, is Clinique’s first guiding ophthalmologist. In the newly created role, Dr. Brissette will help educate consumers on the importance of eye safety, help guide the development of new products, and contribute to C
- 10xBio Completes Enrollment of Phase 2b Trial of Novel Drug for Submental Body Contouringhttps://modernaesthetics.com/news/10xbio-completes-enrollment-of-phase-2b-trial-of-novel-drug-for-submental-body-contouring/2473477/10xBio completed enrollment in a repeat treatment study of its novel injectable drug for submental body contouring. The drug, 10
- Meet the Beauty Health Company’s New CFO: Michael Monahanhttps://modernaesthetics.com/news/meet-the-beauty-health-companys-new-ceo-michael-monahan/2473471/Michael Monahan is The Beauty Health Company’s new Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the transition. "Michael
- Evolus Unveils New Branding for Jeuveauhttps://modernaesthetics.com/news/evolus-unveils-new-branding-for-jeuveau/2473470/Evolus, Inc. is unveiling its new branding for Jeuveau (prabotulinumtoxinA-xvfs). The new Jeuveau imagery reflects today’s consumers, many of whom are millennials and younger. The “Jeuveau, You See Me” marketing campaign uses inclusive messaging to encourage
- Calling all Applicants: Estée Lauder Companies New Incubation Ventures Launches 2023 BEAUTY&YOU India Programhttps://modernaesthetics.com/news/calling-all-applicants-estee-lauder-companies-new-incubation-ventures-launches-2023-beautyyou-india-program/2473469/The Estée Lauder Companies (ELC) is launching the second edition of BEAUTY&YOU. Created by ELC’s New Incubation Ventures and launched in partnership with India’s preferred beauty and lifestyle retailer, NYKAA, BEAUTY&YOU aims to continue its mission to di
- BeautyHealth and LaserAway Expand Partnershiphttps://modernaesthetics.com/news/beautyhealth-and-laseraway-expand-partnership/2473464/The Beauty Health Company will supply Hydrafacial Syndeo devices to LaserAway’s locations across the U.S. and any new practice sites opened through 2025. Syndeo combines Hydrafacial’s patented vortex fusion technology with a digital experience. Using Syndeo’s con
- Venus Concept Introduces Medical Advisory Board for AI.MEhttps://modernaesthetics.com/news/venus-concept-introduces-medical-advisory-board-for-aime/2473449/The primary mission of the medical advisory board will be to provide strategic input, guidance, and clinical recommendations regarding the Company's emerging robotic technology, AI.ME, which received its first 510(k) clearance from the U.S. Food and Drug Administration (FDA) in December 2022,
- ExoCoBio Completes Acquisition of Benevhttps://modernaesthetics.com/news/exocobio-completes-acquisition-of-benev/2473446/ExoCoBio has acquired a majority ownership in BENEV, a global medical aesthetic company that produces growth factor-based skincare products. ExoCoBio produces exosome-based regenerative aesthetics and medicine products and currently holds 54 patents and 15 scientifi